Circulating tumour cell analysis as an early marker for relapse in stage II and III colorectal cancer patients: A pilot study

Clinical and Translational Oncology

Volumn 12, Issue 2, 2010, Pages 142-147

  Garrigós, Noemi ^a   Gallego, Javier ^a,b   Guillén Ponce, Carmen ^a,b   Guaraz, Patricia ^a   García Bautista, Miriam ^a   Castillejo, Adela ^a   Gómez Martínez, Ángeles ^c   Carrato, Alfredo ^a,b,c   Rodríguez Lescure, Álvaro ^a,b   Soto, José L ^a  

^a Elche University Hospital Anexo II   (Spain)

^b Elche University Hospital   (Spain)

^c MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

Circulating tumour cells; Early colorectal cancer; Prognostic markers

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RELAPSE; CANCER STAGING; CELL COUNT; CELL ISOLATION; CLINICAL ARTICLE; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; DISEASE MARKER; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE; MALE; PILOT STUDY; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BLOOD; CARCINOMA; CELL STRAIN HT29; COLORECTAL TUMOR; COMPARATIVE STUDY; EARLY DIAGNOSIS; EVALUATION; FOLLOW UP; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RECURRENT DISEASE; TUMOR EMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CELL COUNT; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HT29 CELLS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; PILOT PROJECTS; RECURRENCE;

EID: 77951641767     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/S12094-010-0479-7     Document Type: Article

References (28)

1. http://www.seom.org/es/prensa/el-cancer-enespanyacom?showall=1
2. Andre T, Boni C, Navarro M et al (2009) Improved survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 27:3109-3116
3. Wolpin BM, Meyerhardt JA, Mamon HJ et al (2007) Adjuvant treatment of colorectal cancer. CA Cancer J Clin 57:168-185
4. Johnstone EC, Kerr DJ (2008) What is the role and impact of molecular markers on treatment decisions in the adjuvant setting of colorectal cancer? Ann Oncol 19[Suppl 7]:vii184-186
5. Weigelt B, Bosma AJ, Hart AA, et al (2003) Marker genes for circulating tumor cells predict survival in metastasized breast cancer patients. Br J Cancer 88:1091-1094
6. Cristofanilli M, Budd GT, Ellis MJ et al (2004) Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351:781-791
7. Cristofanilli M, Hayes DF, Budd GT et al (2005) Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 23:1420-1430
8. Hayes DF, Cristofanilli M, Budd GT et al (2006) Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin Cancer Res 12:4218-4224
9. Smith BM, Slade MJ, English J et al (2000) Response of circulating tumor cells to systemic therapy in patients with metastatic breast cancer: comparison of quantitative polymerase chain reaction and immunocytochemical techniques. J Clin Oncol 18:1432-1439
10. Manhani AR, Manhani R, Soares HP et al (2001) CK-19 expression by RT-PCR in the peripheral blood of breast cancer patients correlates with response to chemotherapy. Breast Cancer Res Treat 66:249-254
11. Smerage JB, Hayes DF (2006) The measurement and therapeutic implications of circulating tumor cells in breast cancer. Br J Cancer 94:8-12
12. Xenidis N, Perraki M, Kafousi M et al (2006) Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients. J Clin Oncol 24:3756-3762
13. Stathopoulou A, Vlachonikolis I, Mavroudis D et al (2002) Molecular detection of cytokeratin-19- positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance. J Clin Oncol 20:3404-3412
14. Cohen SJ, Alpaugh RK, Gross S et al (2006) Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer. Clin Colorectal Cancer 6:125-132
15. Lindemann F, Schlimok G, Dirschedl P et al (1992) Prognostic significance of micrometastatic tumor cells in bone marrow of colorectal cancer patients. Lancet 340:685-689
16. Vlems FA, Wobbes T, Punt CJ et al (2003) Detection and clinical relevance of tumor cells in blood and bone marrow of patients with colorectal cancer. Anticancer Res 23:523-530 (Pubitemid 36358445)
17. Koch M, Kienle P, Kastrati D et al (2006) Prognostic impact of hematogenous tumor cell dissemination in patients with stage II colorectal cancer. Int J Cancer 118:3072-3077
18. Racila E, Euhus D, Weiss AJ et al (1998) Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci USA 95:4589-4594
19. Vona G, Sabile A, Louha M et al (2000) Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulating tumor cells. Am J Pathol 156:57-63
20. Ghossein RA, Bhattacharya S, Rosai J (1999) Molecular detection of micrometastases and circulating tumor cells in solid tumors. Clin Cancer Res 5:1950-1960
21. Bostick PJ, Chatterjee S, Chi DD et al (1998) Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol 16:2632-2640
22. Bessa X, Elizalde JI, Boix L et al (2001) Lack of prognostic influence of circulating tumor cells in peripheral blood of patients with colorectal cancer. Gastroenterology 120:1084-1092
23. Taniguchi T, Makino M, Suzuki K et al (2000) Prognostic significance of reverse transcriptasepolymerase chain reaction measurement of carcinoembryonic antigen mRNA levels in tumor drainage blood and peripheral blood of patients with colorectal carcinoma. Cancer 89:970-976
24. Balic M, Dandachi N, Hofmann G et al (2005) Comparison of two methods for enumerating circulating tumor cells in carcinoma patients. Cytometry B Clin Cytom 68:25-30
25. Allard WJ, Matera J, Miller MC et al (2004) Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 10:6897-6904
26. Moreno JG, O'Hara SM, Gross S et al (2001) Changes in circulating carcinoma cells in patients with metastatic prostate cancer correlate with disease status. Urology 58:386-392
27. Rao CG, Chianese D, Doyle GV et al (2005) Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors. Int J Oncol 27:49-57
28. Cristofanilli M (2006) Circulating tumor cells, disease progression, and survival in metastatic breast cancer. Semin Oncol 33[3 Suppl 9]:S9-14